Rangeley Capital’s Avidity Biosciences RNAM Stock Holding History

Rangeley Capital’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-54,000	Closed	-$3.9M	–	158
2025 Q4	$3.9M	Buy	+54,000	New	+$3.49M	3.23%	8

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Rangeley Capital's RNAM Position: Q1 2026 in Review

Rangeley Capital sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 54,000 shares — an estimated $3.9M sold.

Rangeley Capital first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $3.9M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Rangeley Capital reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Rangeley Capital sold 54,000 Avidity Biosciences shares in Q1 2026, an estimated $3.9M.
Rangeley Capital first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
Rangeley Capital's Avidity Biosciences position peaked at $3.9M in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Rangeley Capital's 13F filing for Q1 2026, filed 15 May 2026.